Muscle-building supplements may up testicular cancer risk

Image
Press Trust of India Washington
Last Updated : Apr 14 2015 | 4:32 PM IST
Men who take muscle-building supplements are at a higher risk of developing testicular cancer, a new study has warned.
Researchers found that men who use muscle-building supplements, such as pills and powders with creatine or androstenedione, are more likely to develop testicular cancer than those who do not, especially if they start before age 25, take more than one supplement, or use the supplements for three or more years.
"The observed relationship was strong," said study senior author Tongzhang Zheng, who led the study at Yale University before joining the Brown University School of Public Health as a professor of epidemiology.
"If you used at earlier age, you had a higher risk. If you used them longer, you had a higher risk. If you used multiple types, you had a higher risk," Zheng said.
The study is the first analytical epidemiological study of the possible link between supplements and testicular cancer, the authors wrote in the British Journal of Cancer.
"Our study found that supplement use was related to a higher risk of developing testicular cancer. These results are important because there are few identified modifiable risk factors for testicular cancer," said Russ Hauser, professor of environmental health science at Harvard TH Chan School of Public Health.
In the study, Zheng's research team conducted detailed interviews of nearly 900 men from Massachusetts and Connecticut - 356 of whom had been diagnosed with testicular germ cell cancer, and 513 who had not.
In the interviews, researchers asked the men not only about their supplement use but also about a wide variety of other possible factors such as smoking, drinking, exercise habits, family history of testicular cancer, and prior injury to their testes or groin.
After tallying their data and accounting for all those possible confounders, as well as age, race, and other demographics, the researchers found that the men who used supplements had a 1.65 odds ratio (65 per cent greater risk) of having developed testicular cancer compared to the men who did not use supplements.
The researchers defined "use" as consuming one or more supplements at least once a week for four consecutive weeks or more.
The odds ratios increased to 2.77 (a 177 per cent greater risk) among men who used more than one kind of supplement, and to 2.56 among men who used supplements three years or longer.
Men who started using supplements at age 25 or younger also had an elevated associated odds ratio of 2.21, the researchers calculated.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 14 2015 | 4:32 PM IST

Next Story